Results 71 to 80 of about 14,707,084 (131)
Network based approach identifies miR‐145‐3p as a central regulatory hub associated to the progression from localized to metastatic medullary thyroid carcinoma
The Journal of Pathology, Volume 270, Issue 4, Page 468-480, December 2026.Abstract
Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor originating from calcitonin producing C‐cells and accounts for 1–5% of thyroid cancers. Total thyroidectomy is curative in localized disease (N0), whereas lymph node metastases (N1) are associated with poorer prognosis.Anna Citarella, Manuela Petti, Zein Mersini Besharat, Caterina Alfano, Elena Splendiani, Sofia Trocchianesi, Sara Cassandro, Martina Chiacchiarini, Claudia Sabato, Francesca Gianno, Tanja Milena Autilio, Martina Brunetti, Giuseppina Catanzaro, Antonella Verrienti, Rossella Elisei, Raffaele Ciampi, Cristina Romei, Maria Grazia Castagna, Silvia Cantara, Vincenzo Marotta, Luciano Pezzullo, Lorenzo Farina, Cosimo Durante, Agnese Po, Elisabetta Ferretti +24 morewiley +1 more sourceMutação BRAF em pacientes idosos submetidos à tireoidectomia
Revista do Colégio Brasileiro de CirurgiõesOBJETIVO: Avaliar a frequência da mutação V600E do gene BRAF em pacientes com mais de 65 anos de idade submetidos à tireoidectomia, correlacionando sua presença ou ausência com as diferentes lesões histológicas, com as variantes e com fatores ...Antonio Augusto T. Bertelli, Antonio José Gonçalves, Marcelo B. Menezes, Murilo R. Melo, Stefano Tincani, Luiz Cláudio Bosco Massarollo +5 moredoaj +1 more sourceThe role of miR‐335‐5p in the redifferentiation of BRAF p.V600E thyroid cancers
Molecular Oncology, Volume 20, Issue 11, Page 2955-2973, November 2026.The BRAF p.V600E mutation promotes thyroid cancer dedifferentiation and radioiodine resistance. Using a network approach, we identified miR‐335‐5p as a key regulator of BRAF‐mutated thyroid tumors. Restoring miR‐335‐5p increased thyroid‐specific gene expression and iodine uptake in cells and organoids.Valeria Pecce, Simone Bini, Marialuisa Sponziello, Giorgio Grani, Giulia Fiscon, Paola Paci, Lorenzo Farina, Rosa Falcone, Valentina Maggisano, Sebastiano Filetti, Cosimo Durante, Antonella Verrienti +11 morewiley +1 more sourcePAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model
Molecular Oncology, Volume 20, Issue 11, Page 2764-2783, November 2026.Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.Luisa Schwarzmüller, Janina Müller, Efstathios‐Iason Vlachavas, Lukas Beumers, Lena Fleischhacker, Sara Burmester, Angelika Wörner, Sabine Karolus, Dominic Helm, Cindy Körner, Stefan Wiemann +10 morewiley +1 more sourceConsistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens
, 2017 Molecular testing of cytological lung cancer specimens includes, beyond epidermal growth factor receptor (EGFR), emerging predictive/prognostic genomic biomarkers such as Kirsten rat sarcoma viral oncogene homolog (KRAS), neuroblastoma RAS viral [v-ras ...Bihl M, Serra, N., Barberis M, Bongiovanni, M., Bongiovanni M, Vielh, P., Tallini, G., Luthra R, Roy-Chowdhuri S, Basolo, F., Fontanini G, Pepe, F., Kamel-Reid, S., Barberis, M., Vigliar, E., da Cunha Santos, G., Fassan M, Schmitt, F., Salto-Tellez M, Stieber D, Nikiforov YE, Missiaglia E, Troncone G, Serra N, Pisapia, P., Rugge M, Nikiforov, Y.E., Basolo F, Sholl, L.M., Missiaglia, E., Rappa, A., Pepe F, Salto-Tellez, M., Malapelle U, Vigliar E, Weynand B, Rosell, R., de Biase, D., Savic, S., Luthra, R., Weynand, B., da Cunha Santos G, Nikiforova, M.N., Roy-Chowdhuri, S., Savic S, Lozano, M.D., Bubendorf L, Sholl LM, Rosell R, de Andrea, C.E., Mayo-de-Las-Casas C, Nikiforova MN, Fontanini, G., Vielh P, Bihl, M., Vander Borght, S., de Biase D, Mayo-de-Las-Casas, C., Stieber, D., Vander Borght S, Molina-Vila, M.A., Fassan, M., Hwang DH, Bubendorf, L., Molina-Vila MA, Rugge, M., Malapelle, U., Bellevicine C, Kamel-Reid S, de Andrea CE, Tallini G, Schmitt F, Rappa A, Hwang, D.H., Troncone, G., Pisapia P, Bellevicine, C., Lozano MD, Clara Mayo-de-Las-Casas, da Cunha Santos, Gilda, Yuri E. Nikiforov, Nicola Serra, Tallini, Giovanni, Bongiovanni, Massimo, Lozano, Maria D., Francesco Pepe, Umberto Malapelle, Rajyalakshmi Luthra, David H. Hwang, Lynette M. Sholl, Massimo Barberis, Pisapia, Pasquale, Hwang, David H, null null, Alessandra Rappa, de Andrea, Carlos E, Roy Chowdhuri, Sinchita, Gilda da Cunha Santos, Fassan, Matteo, Bubendorf, Lukas, Kamel-Reid, Suzanne, Rappa, Alessandra, Nikiforov, Yuri E, Fernando Schmitt, Fulvio Basolo, Marina N. Nikiforova, Pasquale Pisapia, Sholl, Lynette M., Matteo Fassan, Molina-Vila, Miguel A, Barberis, Massimo, Missiaglia, Edoardo, Vielh, Philippe, Molina Vila, Miguel A., Dario de Biase, Sinchita Roy-Chowdhuri, Hwang, David H., Mayo de Las Casas, Clara, Lukas Bubendorf, Elena Vigliar, Maria D. Lozano, Savic, Spasenija, Troncone, Giancarlo, Philippe Vielh, Carlos E. de Andrea, Salto Tellez, Manuel, Mayo-de-Las-Casas, Clara, Vander Borght, Sara, Bihl, Michel, Spasenija Savic, Massimo Bongiovanni, Serra, Nicola, Edoardo Missiaglia, Sholl, Lynette M, Daniel Stieber, Pepe, Francesco, Massimo Rugge, Nikiforova, Marina N., Birgit Weynand, Giancarlo Troncone, Michel Bihl, Schmitt, Fernando, Sara Vander Borght, Roy-Chowdhuri, Sinchita, Suzanne Kamel-Reid, Vigliar, Elena, Weynand, Birgit, de Andrea, Carlos E., Gabriella Fontanini, Rosell, Rafael, Stieber, Daniel, Miguel A. Molina-Vila, de Biase, Dario, Lozano, Maria D, Malapelle, Umberto, Nikiforov, Yuri E., BASOLO, FULVIO, Rugge, Massimo, Bellevicine, Claudio, Luthra, Rajyalakshmi, Claudio Bellevicine, Salto-Tellez, Manuel, FONTANINI, GABRIELLA, Nikiforova, Marina N, Kamel Reid, Suzanne, Molina Vila, Miguel A, Manuel Salto-Tellez, Giovanni Tallini, Rafael Rosell +168 morecore +2 more sourcesRedifferentiation therapy prior to radioiodine in refractory differentiated thyroid cancer: A systematic review and meta-analysis
Revista Colombiana de Endocrinología, Diabetes y Metabolismo
Background: Radioiodine (RAI)-refractory differentiated thyroid cancer (DTC) has a poor prognosis. Constitutive MAPK activation, frequently driven by BRAF V600E or RAS alterations, suppresses thyroid-specific genes and sodium-iodide symporter expression.Carlos Eduardo Jimenez Canizales, Rafael Parra-Medina, Cesar Payan-Gómez, Carlos Hernán Calderón Franco, Roberta Modica, Elio Benevento, Alfredo Ernesto Romero-Rojas, Mireya Tapiero García, Juan Felipe Pérez Echavarría +8 moredoaj +1 more sourceDivergent Roles of PIK3C3 in KRAS‐Wild‐Type and KRAS‐Mutant Advanced Colorectal Cancer: Implications for 5‐Fluorouracil Sensitivity and Prognosis
Cancer Medicine, Volume 15, Issue 11, November 2026.PIK3C3 plays divergent roles in KRAS‐WT and KRAS‐mutant CRCs, viz. targeting PIK3C3 suppresses KRAS/ERK pathway in KRAS‐WT CRC, while enhancing 5‐FU sensitivity in KRAS‐mutant CRC. ABSTRACT Introduction
Phosphatidylinositol 3‐kinase catalytic subunit type 3 (PIK3C3) is central to autophagy, which supports cancer adaptation to environmental stresses and Chien‐An Chu, Nan‐Haw Chow, Jiu‐Yao Wang, Chen Chang, Peng‐Chan Lin, Yu‐Min Yeh, Bo‐Wen Lin, Yi‐Wen Wang, Yun‐Hao Dai, Yi‐Lin Chen, Po‐Chuan Chen, Shang‐Hung Chen, Ren‐Hao Chan, Chung‐Liang Ho, Che‐Wei Hsu, Chung‐Ta Lee +15 morewiley +1 more source